全球医用塑胶市场规模（按产品类型、製程技术、应用、区域范围和预测）

医用塑胶市场规模及预测

2024 年医用塑胶市场规模为 267.8 亿美元，预计到 2032 年将达到 446.6 亿美元，2026 年至 2032 年的复合年增长率为 6.60%。

医用塑胶是现代医疗保健的重要组成部分，促进了各种医疗设备和器械的开发和使用。

这些特种聚合物具有生物相容性、耐久性和耐灭菌性等优异性能，非常适合医疗领域的应用。

医用级塑胶经过精心设计，与人体组织和体液相容，最大限度地降低了副作用的风险。

医用塑胶具有优异的耐用性，甚至可以承受灭菌过程，从而延长医疗设备的使用寿命。

医用塑胶具有高度可自订性，可以製造满足特定要求的设备，包括灵活性、强度和透明度。

与其他材料相比，医用级塑胶是一种经济高效的选择，尤其是对于一次性医疗器材而言。

全球医用塑胶市场动态

影响全球医用塑胶市场的关键市场动态是：

关键市场驱动因素

一次性医疗设备需求不断增长：感染疾病的上升正在推动一次性医疗设备的需求。例如，2024年2月12日，美国碧迪公司（BD）宣布投资12亿美元扩建其一次性医疗医疗设备生产设施，以满足全球一次性医疗产品激增的需求。

老年医疗设备应用领域不断拓展：老龄人口的成长推动了各种医疗保健应用领域对医用塑胶的需求。根据联合国报告，2023年，全球65岁以上人口将增加3.5%。例如，科思创于2024年3月5日推出了一系列专为老年医疗设备设计的全新生物相容性聚合物，以满足老龄化社会的独特需求。

微创手术日益普及：向微创手术的转变正在推动医用塑胶的应用。例如，赢创工业集团于2024年1月20日推出了一种用于腹腔镜手术器械的新型高性能聚合物，以提高其耐用性并缩短手术时间。

更加重视感染控制：人们对医疗相关感染的担忧日益加剧，这推动了对抗菌塑胶的需求。美国疾病管制与预防中心 (CDC) 报告称，到 2023 年，使用抗菌塑胶的医疗机构的医疗相关感染率将下降 22%。

主要问题

监管障碍阻碍市场准入：医疗设备产业必须遵守严格的法规，以确保其安全性和有效性。遵守这些法规的过程复杂且耗时，阻碍了新型医用塑胶产品进入市场。

替代材料的竞争阻碍市场成长：医用塑胶面临来自金属和陶瓷等其他材料的竞争，这些材料可能适用于某些应用。这些替代材料可能在强度、耐用性、生物相容性等方面具有优势，这限制了医用塑胶的市场占有率。

创新挑战：材料科学和製造流程的发展对于开发创新医用塑胶至关重要，但技术限制可能会阻碍具有改进性能和应用的新材料的创造。

供应链中断阻碍生产：全球医用塑胶供应链容易受到自然灾害、地缘政治事件、景气衰退等因素造成的中断的影响。这些中断可能导致原材料短缺、成本上升和生产延迟。

主要趋势

药物输送系统应用不断扩展：药物输送技术的进步正在推动医用塑胶的创新。 2023年，美国食品药物管理局（FDA）核准了53种采用先进聚合物的新型药物输送装置。例如，2024年2月28日，索尔维宣布在可植入药物释放型聚合物研发方面取得突破，这可能会彻底改变慢性病的长期用药方式。

家庭医疗保健设备需求不断增长：家庭护理的日益增长趋势推动了对耐用、易用的医用级塑胶的需求。根据美国居家照护和临终关怀协会的数据，美国家庭医疗保健市场到2023年将成长8.5%。

更重视永续性：人们对环境影响的日益关注，正推动生物基和可回收医用塑胶的创新。例如，杜邦公司于2024年1月5日宣布，到2030年，其50%的医用塑胶将由可再生资源生产，并将率先推出一系列全新的生物基手术器械手柄。

3D列印应用不断扩展：3D列印在医疗保健领域的日益普及，推动了特种医用塑胶的需求。美国食品药物管理局（FDA）在2023年核准了35种3D列印医疗设备，与前一年同期比较增加了25%。例如，2024年4月10日，Stratasys Ltd.宣布推出一系列用于3D列印义肢和手术导板的新型生物相容性树脂，增强了患者照护的客製化能力。

目录

第一章全球医用塑胶市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球医用塑胶市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球医用塑胶市场（依产品类型）

• 概述
• 聚乙烯（PE）
• 聚丙烯（PP）
• 聚碳酸酯（PC）
• 其他的

6. 全球医用塑胶市场（依工艺技术划分）

• 概述
• 挤压
• 射出成型
• 吹塑成型
• 其他的

第七章 全球医用塑胶市场（按应用）

• 医疗设备包装
• 医疗部件
• 整形外科植入包装
• 整形外科非耐用品
• 其他的

8. 全球医用塑胶市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章：全球医用塑胶市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• EASTMAN CHEMICAL COMPANY
• CELANESE CORPORATION
• COVESTRO AG
• SOLVAY
• THE LUBRIZOL CORPORATION
• EVONIK INDUSTRIES AG
• SAINT-GOBAIN PERFORMANCE PLASTICS
• TRINSEO
• ENSINGER
• TEKNI-PLEX

第十章 附录

• 相关调查

Medical Plastics Market Size and Forecast

Medical Plastics Market size was valued at USD 26.78 Billion in 2024 and is projected to reach USD 44.66 Billion by 2032, growing at a CAGR of 6.60% from 2026 to 2032.

Medical plastics serve as indispensable components within contemporary healthcare, facilitating the development and utilization of a broad spectrum of medical devices and equipment.

These specialized polymers exhibit exceptional properties, such as biocompatibility, durability, and resistance to sterilization, rendering them ideally suited for applications within the medical domain.

Medical plastics are meticulously designed to be compatible with human tissues and fluids, minimizing the risk of adverse reactions.

Medical plastics exhibit exceptional durability, capable of withstanding sterilization processes and ensuring the longevity of medical devices.

Medical plastics offer a high degree of customization, allowing for the creation of devices tailored to specific requirements, such as flexibility, strength, and transparency.

Medical plastics can represent a cost-effective option compared to other materials, particularly for disposable devices.

Global Medical Plastics Market Dynamics

The key market dynamics that are shaping the global medical plastics market include:

Key Market Drivers

Rising Demand for Disposable Medical Devices: The increasing prevalence of infectious diseases is fueling the need for disposable medical devices. For instance, in February 12, 2024, Becton, Dickinson and Company (BD) announced a $1.2 billion investment to expand its disposable medical device production facilities, aiming to meet the surging global demand for single-use medical products.

Expanding Applications for Geriatric Care Devices: The expanding elderly demographic is driving demand for medical plastics in various healthcare applications. The UN reported that the global population aged 65 and above grew by 3.5% in 2023. For instance, in March 5, 2024, Covestro launched a new line of biocompatible polymers specifically designed for geriatric care devices, addressing the unique needs of the aging population.

Increasing Adoption of Minimally Invasive Surgeries: The shift towards less invasive surgical procedures is boosting the use of medical plastics. For instance, in January 20, 2024, Evonik Industries introduced a new high-performance polymer for laparoscopic surgical instruments, enhancing durability and reducing procedure times.

Rising Focus on Infection Control: Growing concerns about healthcare-associated infections are propelling the demand for antimicrobial plastics. The CDC reported a 22% reduction in healthcare-associated infections in facilities using antimicrobial plastics in 2023.

Key Challenges:

Regulatory Hurdles Hindering Market Entry: The medical device industry is subject to stringent regulations to ensure safety and efficacy. Compliance with these regulations can be complex and time-consuming, hindering market entry for new medical plastic products.

Competition from Alternative Materials Hampering Market Growth: Medical plastics face competition from other materials, such as metals and ceramics, which may be suitable for certain applications. These alternative materials can offer advantages in terms of strength, durability, or biocompatibility, limiting the market share of medical plastics.

Technological Limitations Challenging Innovation: Advancements in materials science and manufacturing processes are essential for the development of innovative medical plastics. However, limitations in technology can hinder the creation of new materials with improved properties and applications.

Supply Chain Disruptions Obstructing Production: The global supply chain for medical plastics can be vulnerable to disruptions, such as those caused by natural disasters, geopolitical events, or economic downturns. These disruptions can lead to shortages of raw materials, increased costs, and delays in production.

Key Trends

Expanding Applications in Drug Delivery Systems: The evolving field of drug delivery is fueling innovations in medical plastics. The FDA approved 53 new drug delivery devices utilizing advanced polymers in 2023. For instance, in February 28, 2024, Solvay announced a breakthrough in its development of implantable drug-eluting polymers, potentially revolutionizing long-term medication administration for chronic conditions.

Increasing Demand for Home Healthcare Devices: The growing trend of home-based care is driving the need for durable, user-friendly medical plastics. The U.S. Home Healthcare Market grew by 8.5% in 2023, according to the National Association for Home Care & Hospice.

Rising Emphasis on Sustainability: The growing focus on environmental impact is fueling innovations in bio-based and recyclable medical plastics. For instance, in January 5, 2024, DuPont announced its commitment to making 50% of its medical-grade plastics from renewable resources by 2030, starting with a new line of bio-based surgical instrument handles.

Expanding 3D Printing Applications: The increasing use of 3D printing in healthcare is driving demand for specialized medical plastics. The FDA cleared 35 3D-printed medical devices in 2023, a 25% increase from the previous year. For instance, in April 10, 2024, Stratasys Ltd. unveiled a new range of biocompatible resins for 3D-printed prosthetics and surgical guides, enhancing customization capabilities in patient care.

Global Medical Plastics Market Regional Analysis

Here is a more detailed regional analysis of the global medical plastics market:

North America:

North America is dominating the global medical plastics market, driven by advanced healthcare infrastructure and continuous technological innovations.

According to the U.S. Food and Drug Administration, the use of medical-grade plastics in approved devices increased by 18% in 2023 compared to the previous year.

For instance, in March 2, 2024, when Dow Chemical Company announced a $500 million investment in its Michigan facilities to expand production of high-performance medical plastics, focusing on materials for drug delivery systems and diagnostic equipment.

The region's market leadership is also supported by stringent regulations and a growing emphasis on patient safety.

Health Canada reported that 72% of newly registered medical devices in 2023 incorporated advanced polymers, highlighting the shift towards more durable and biocompatible materials.

For instance, in April 8, 2024, 3M Healthcare unveiled a new line of antimicrobial medical plastics, developed in collaboration with leading U.S. hospitals to combat healthcare-associated infections.

This innovation, coupled with the region's robust research and development capabilities, continues to solidify North America's position at the forefront of the global medical plastics market.

Europe:

The European region is projected to experience a rapid CAGR growth during the forecast period, driven by stringent regulations promoting safety and sustainability in healthcare.

According to the European Commission, the use of advanced medical plastics in healthcare facilities increased by 18% in 2023, with a particular focus on antimicrobial and eco-friendly materials.

This trend was further accelerated on March 8, 2024, when Borealis AG, a leading provider of innovative plastics solutions, announced a €200 million investment in its medical-grade polymer production facilities across Europe, aiming to meet the growing demand for high-performance, sustainable medical plastics.

Europe's market expansion is also fueled by technological advancements and an aging population requiring more medical interventions.

Eurostat reported that the proportion of the EU population aged 65 and over reached 20.8% in 2023, driving demand for specialized medical devices.

For instance, in February 15, 2024, Evonik Industries unveiled a new line of bio-based polymers for orthopedic implants, developed in collaboration with leading European research institutions. This innovation, coupled with the European Medicines Agency's approval of 28 new drug-device combination products utilizing advanced polymers in 2023, underscores the region's potential for continued rapid growth in the medical plastics market.

Global Medical Plastics Market: Segmentation Analysis

The Global Medical Plastics Market is segmented based on Product Type, Process Technology, Application, and Geography.

Medical Plastics Market, By Product Type

• Polyethylene (PE)
• Polypropylene (PP)
• Polycarbonate (PC)
• Others

Based on Product Type, the Global Medical Plastics Market is bifurcated into Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Others. The polyethylene (PE) segment is dominating the medical plastics market, driven by its versatility, biocompatibility, and cost-effectiveness. However, the polypropylene (PP) segment is experiencing rapid growth, fueled by its superior mechanical properties, such as higher melting point and rigidity, making it suitable for a wider range of medical applications.

Medical Plastics Market, By Process Technology

• Extrusion
• Injection Molding
• Blow Molding
• Others

Based on Process Technology, the Global Medical Plastics Market is bifurcated into Extrusion, Injection Molding, Blow Molding, Others. The extrusion segment is currently dominating the medical plastics market, driven by its versatility and ability to produce a wide range of products, such as tubes, catheters, and packaging materials. However, the injection molding segment is experiencing rapid growth, as it allows for the production of more complex and precise medical devices, including syringes, diagnostic kits, and surgical instruments.

Medical Plastics Market, By Application

• Medical Device Packaging
• Medical Components
• Orthopedic Implant Packaging
• Orthopedic Soft Goods
• Others

Based on Application, the Global Medical Plastics Market is bifurcated into Medical Device Packaging, Medical Components, Orthopedic Implant Packaging, Orthopedic Soft Goods, Others. The medical device packaging segment is currently dominating the medical plastics market, driven by the increasing demand for safe and effective packaging solutions for a wide range of medical devices. However, the orthopedic soft goods segment is experiencing rapid growth, fueled by the rising demand for disposable medical products, such as surgical gowns, drapes, and masks.

Medical Plastics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Medical Plastics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is dominating the global medical plastics market, driven by advanced healthcare infrastructure and continuous technological innovations. However, the European region is projected to experience a rapid CAGR growth during the forecast period, driven by stringent regulations promoting safety and sustainability in healthcare.

Key Players

The "Global Medical Plastics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Rochling SE & Co. KG; Nolato AB; Saint-Gobain; SABIC; Orthoplastics Ltd; Eastman Chemical Company; Celanese Corporation; Dow, Inc.; Tekni-Plex, Inc.; Solvay S.A.; HMC Polymers Company Limited.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Medical Plastics Market Key Developments

• In February 2023, Cleanse Corporation has strategically acquired DuPont's mobility and mobility business for a significant sum of USD 11.00 billion, expanding its global reach and bolstering its offerings within the environmental sector, particularly in sustainable transportation.
• In June 2023, SABIC has acquired Clariant's stake in Scientific Design, a renowned catalysis leader, strengthening its non-cyclical, technology-driven business and solidifying its position as a global specialist in the field.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL PLASTICS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MEDICAL PLASTICS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MEDICAL PLASTICS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Polyethylene (PE)
• 5.3 Polypropylene (PP)
• 5.4 Polycarbonate (PC)
• 5.5 Others

6 GLOBAL MEDICAL PLASTICS MARKET, BY PROCESS TECHNOLOGY

• 6.1 Overview
• 6.2 Extrusion
• 6.3 Injection Molding
• 6.4 Blow Molding
• 6.5 Others

7. Medical Plastics Market, By Application

• 7.1 Medical Device Packaging
• 7.2 Medical Components
• 7.3 Orthopedic Implant Packaging
• 7.4 Orthopedic Soft Goods
• 7.5 Others

8 GLOBAL MEDICAL PLASTICS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East Africa

9 GLOBAL MEDICAL PLASTICS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 EASTMAN CHEMICAL COMPANY
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 CELANESE CORPORATION
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 COVESTRO AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 SOLVAY
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 THE LUBRIZOL CORPORATION
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 EVONIK INDUSTRIES AG
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 SAINT-GOBAIN PERFORMANCE PLASTICS
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 TRINSEO
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.10 ENSINGER
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.10 TEKNI-PLEX
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research